GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...

Two specialists at Phoenix-based Valley Eye Specialists were among the first group of surgeons in the nation to implant the Alcon Acrysof IQ Vivity Lens after FDA approval, according to a Feb. 1 news ...

Lance Kugler, MD, of Omaha, Neb.-based Kugler Vision, is slated to be the first surgeon in eastern Nebraska to use Acrysof IQ Vivity Lens from Geneva, Switzerland-based Alcon, according to an Oct. 27 ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity®, the most widely implanted9 extended depth of focus (EDOF) intraocular ...

For almost 20 years now, we have been using presbyopia-correcting lens implants. But an important caveat that came with all of them is that they can only be used safely in eyes with near-perfect ...

Disclaimer: This is sponsored content paid for by Vision for Life. All opinions and views are of the advertiser and does not reflect the same of NewsChannel 5 Nashville. In today’s Your Health Matters ...

Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...